Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Similar documents
Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Clinical Global Impression (CGI)

Epworth Sleepiness Scale (ESS)

Michigan Neuropathy Screening Instrument (MNSI)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Hospital Anxiety and Depression Scale (HADS)

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Pain Relief (PR) Notes to Readers

Barnes Akathisia Rating Scale (BARS)

Disability Assessment for Dementia (DAD)

Neuropathic Pain Scale (NPS)

Timed Up and Go (TUG)

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS

With additional support from Florida International University and The Children s Trust.

Let s Create Standard Value Level Metadata

Screening for Depression and Suicide Risk Assessment

ECZTRA 3. Efficacy Assessment & C-SSRS Manual

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

C-SSRS/KIT version includes. C-SSRS Scoring/ Administration instructions (13pgs)

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

CDISC BrCa TAUG & Oncology Information Session

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

PharmaSUG Paper DS12

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

Methodological approach to the use and interpretation of baseline history of suicidal ideation and behavior Sarah DuBrava Pfizer, Inc

BUILDING BARRIERS TO SUICIDE:

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

LOUDOUN COUNTY PUBLIC SCHOOLS Department of Pupil Services. Suicide Prevention Guidelines

PharmaSUG Paper DS04

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

ISCTM SIB Consensus Statements for the Nomenclature & Classification Working Group

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2018 CMS Web Interface

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Clinical Trial Database Analyses to Inform Regulatory Guidances Suicidal Ideation and Behavior Assessment

How to - Trial Summary Parameter. CJUG SDTM Team : LISaS

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

CDISC - Mapping New Pathways for Novartis. Darren Weston, Project Leader Pat Majcher, Senior Principal Programmer

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

Suicide Prevention and Intervention

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Clinical Review Report (Sample)

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

**Please read the DQA Measures User Guide prior to implementing this measure.**

Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction - National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

E11(R1) Addendum to E11: Clinical Investigation of Medicinal Products in the Pediatric Population Step4

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Measure #69 (NQF 0380): Hematology: Multiple Myeloma: Treatment with Bisphosphonates National Quality Strategy Domain: Effective Clinical Care

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

Quality ID #195 (NQF 0507): Radiology: Stenosis Measurement in Carotid Imaging Reports National Quality Strategy Domain: Effective Clinical Care

2018 CMS Web Interface

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

Breast Cancer TAUG Overview and Implementation

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Intermediate Outcome

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Measure Reporting via Registry: CPT only copyright 2015 American Medical Association. All rights reserved. 11/17/2015 Page 1 of 9

Suicide Prevention & The Art of Asking: Bridging Clinical Assessment and Community Conversations to Promote Awareness and Prevention

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

May and Klonsky s (2016) meta-analysis of factors

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

2018 CMS Web Interface

Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period National Quality Strategy Domain: Patient Safety

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

Quality ID #397: Melanoma Reporting National Quality Strategy Domain: Communication and Care Coordination

SDTMIG v3.3 Batch 2 Upcoming Public Review. Presented by Fred Wood

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

2019 CMS Web Interface

GUIDANCE FOR SAMPLING ART CLINICS IN COUNTRIES COMBINING SURVEILLANCE OF PRE-TREATMENT HIV DRUG RESISTANCE AND ACQUIRED HIV DRUG RESISTANCE AT 12 AND

Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Transcription:

Columbia-Suicide Severity Rating Scale Baseline ( ) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Notes to Readers This implementation guide is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes 2012-03-03 0.1 Columbia-Suicide Severity Rating Scale Baseline ( ) Draft 2012-08-07 1.0 Columbia-Suicide Severity Rating Scale Baseline ( )

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) 1 Introduction This document describes the CDISC implementation of the Baseline questionnaire, a standard questionnaire administered on a CRF that is typically used in clinical trials to measure pain response. The CRF preceded the CDISC CDASH CRF standards and based on its copyright status, cannot be modified to CDASH standards. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain table, which can be found at the CDISC website at: (http://www.cdisc.org/sdtm) These specific implementation details for this specific questionnaire are meant to be used in conjunction with the SDTMIG, but are recorded separately since this questionnaire may be used in many different therapeutic area implementations. All questionnaire documentation can be found on the CDISC web site at: (http://www.cdisc.org/content2909) The CDISC Intellectual Property Policy can be found on the CDISC web site at: (http://www.cdisc.org/bylaws-and-policies) 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2 Copyright Status CDISC has obtained permission to include the Baseline questionnaire as part of CDISC Data Standards. This means that CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. The instrument itself was not changed. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples and (3) case report forms annotated with the CDISC SDTMIG submission values. CDISC has developed this documentation at no cost to copyright holder or any additional cost to users of the instrument beyond the normal licenses fees charged by the copyright holder. CDISC acknowledges Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; Mann, J.; copyright 2008 The Research Foundation for Mental Hygiene, Inc. for the agreement to include the Columbia-Suicidality Severity Rating Scale () baseline version 2009-01-14 scale in the CDISC data standards. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) The author s consent ensures that the data captured using this instrument will be done so in a standardized manner thereby facilitating collection, database storage, reporting and regulatory review of that data. CDISC wants to emphasize that the existing copyright status as well as the existing procedures for licensing fees and using the instrument will remain exactly as they have been. Please follow the instrument owners own mechanisms for permissions and licenses if you have a need to use this questionnaire. 3 The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions for the QS domain from the SDTMIG apply for this supplemental implementation guide including those referenced in the CDISC notes. Additionally, the following assumptions apply to the Columbia-Suicide Severity Rating Scale Baseline Form: 1. Columbia-Suicide Severity Rating Scale Baseline Form ( ): C- SSRS Baseline is a suicidal ideation rating scale. It rates an individual's degree of suicidal ideation on a scale, ranging from "wish to be dead" to "active suicidal ideation with specific plan and intent." 2. The C-SSR is to be provided at a baseline visit. QSTPT=Baseline provides that time point reference. 3. The evaluator of the questionnaire is stored in QSEVAL and for the form the INVESTIGATOR provides the evaluation. 4. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. A full list of value sets for QSORRES, QSSTRESC and QSSTRESN fields is provided in Section 4: Mapping Strategy. 3.2 Example for Columbia-Suicide Severity Rating Scale Baseline Domain Model The Baseline example below shows the terminology for QSCAT, QSTEST, QSTESTCD and QSORRES that should be utilized for this scale. Values for QSORRES are for prospective data collection. Sponsors mapping legacy data should retain legacy values for QSORRES. A full list of value sets for QSORRES, QSSTRESC and QSSTRESN fields are listed in Section 4: Mapping Strategy. 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) Example: Columbia-Suicide Severity Rating Scale Baseline ( Baseline) This example shows data from one subject collected at one visit for a Baseline questionnaire. The example uses standard controlled terminology for QSTESTCD, QSTEST, QSCAT and QSSORRES for the measure. Rows 1-39: Represent the questions from the Form. All original results are represented with the standard terminology in QSORRES. This result is then transformed into a Standard Numeric score in QSSTRESN. Row 8, 10 and 27 are for illustrative purposes in order to display the QSTESTCD/QSTEST values and contain the value of XXX, the actual missing record would not be created in the QS domain QS.XPT Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSEVAL VISITNUM QSTPT CSS01-Wish to 1 STUDYX QS 1 CSS0101 be Dead CSS01-Wish to 2 STUDYX QS 2 CSS0101A be Dead, Wish dead Wish dead INVESTIGATOR 1 Baseline Describe 3 STUDYX QS 4 STUDYX QS 5 STUDYX QS 6 STUDYX QS 7 STUDYX QS 8 STUDYX QS 9 STUDYX QS 10 STUDYX QS 11 STUDYX QS 12 STUDYX QS 3 CSS0102 4 CSS0102A 5 CSS0103 6 CSS0103A 7 CSS0104 8 CSS0104A 9 CSS0105 10 CSS0105A 11 CSS0106 12 CSS0106A CSS01-Non- Specific Suicidal Thought CSS01-Non- Specific Suicid Thought, Descr CSS01-Suicidal Ideation-No Intent CSS01-Suicidal Ideation-No Intent, Descr CSS01-Ideation With Intent, No Plan CSS01-Ideation With Intent No Plan Descr CSS01-Ideation With Plan/Intent CSS01-Ideation With Plan/Intent, Descr Severe Ideation Severe Ideation, Description I have thought about killing myself I have thought about killing myself INVESTIGATOR 1 Baseline I thought about taking an overdose but I never made a specific plan I thought about taking an overdose but I never made a specific plan INVESTIGATOR 1 Baseline No N INVESTIGATOR 1 Baseline XXX INVESTIGATOR 1 Baseline No N INVESTIGATOR 1 Baseline XXX INVESTIGATOR 1 Baseline 2 2 2 INVESTIGATOR 1 Baseline Some intent to act Some intent to act on suicidal on suicidal INVESTIGATOR 1 Baseline thoughts thoughts 13 STUDYX QS 13 CSS0107 2-5 times in week 3 3 INVESTIGATOR 1 Baseline 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSEVAL VISITNUM QSTPT Severe Ideation, Frequency Less than 1 14 STUDYX QS 14 CSS0108 Severe Ideation, hour/some of the 2 2 INVESTIGATOR 1 Baseline Duration time 15 STUDYX QS 16 STUDYX QS 17 STUDYX QS 18 STUDYX QS 19 STUDYX QS 20 STUDYX QS 21 STUDYX QS 22 STUDYX QS 23 STUDYX QS 24 STUDYX QS 25 STUDYX QS 26 STUDYX QS 27 STUDYX QS 28 STUDYX QS 29 STUDYX QS 15 CSS0109 16 CSS0110 17 CSS0111 18 CSS0112 19 CSS0113 20 CSS0113A 21 CSS0114 22 CSS0115 23 CSS0116 24 CSS0116A 25 CSS0117 26 CSS0118 27 CSS0118A 28 CSS0119 29 CSS0119A Severe Ideation, Control Severe Ideation, Deterrents Severe Ideation, Reasons CSS01-Actual Attempt CSS01-Number of Actual Attempts CSS01-Actual Attempt, Describe CSS01-Nonsuicidal Selfinjurious Behav CSS01- Interrupted Attempt CSS01-Number of Interrupted Attempts CSS01- Interrupted Attempt, Describe CSS01-Aborted Attempt CSS01-Number of Aborted Attempts CSS01-Aborted Attempt, Describe CSS01- Preparatory Acts/Behavior CSS01- Preparatory Acts/Behavior, Can control thoughts with a lot of difficulty Deterrents definitely did not stop you Mostly to get attention, revenge or a reaction from others 4 4 INVESTIGATOR 1 Baseline 5 5 INVESTIGATOR 1 Baseline 2 2 INVESTIGATOR 1 Baseline 2 2 2 INVESTIGATOR 1 Baseline Try to get injured to get attention Try to get injured to get attention INVESTIGATOR 1 Baseline 1 1 1 INVESTIGATOR 1 Baseline Stopped from overdose Stopped from overdose INVESTIGATOR 1 Baseline No N INVESTIGATOR 1 Baseline 0 0 0 INVESTIGATOR 1 Baseline XXX INVESTIGATOR 1 Baseline Buying pills Buying pills INVESTIGATOR 1 Baseline 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSEVAL VISITNUM QSTPT Descr 30 STUDYX QS CSS01-Suicidal 30 CSS0120 Behavior No N INVESTIGATOR 1 Baseline 31 STUDYX QS 31 CSS0121A Recent Attempt Date 2010-11-09 2010-11-09 INVESTIGATOR 1 Baseline 32 STUDYX QS 33 STUDYX QS 34 STUDYX QS 35 STUDYX QS 36 STUDYX QS 37 STUDYX QS 38 STUDYX QS 39 STUDYX QS 32 CSS0121B 33 CSS0121C 34 CSS0122A 35 CSS0122B 36 CSS0122C 37 CSS0123A 38 CSS0123B 39 CSS0123C Recent Attempt Damage Recent Attempt Potential Lethal Attempt Date Lethal Attempt Damage Lethal Attempt Potential CSS01-First Attempt Date CSS01-First Attempt Damage CSS01-First Attempt Potential Minor physical damage Behavior likely to result in injury but not likely to cause death 1 1 INVESTIGATOR 1 Baseline 1 1 INVESTIGATOR 1 Baseline 2009-03-27 2009-03-27 INVESTIGATOR 1 Baseline Severe physical damage 4 4 INVESTIGATOR 1 Baseline Behavior likely to medical care result in death despite available 2 2 INVESTIGATOR 1 Baseline 2009-02-12 2009-02-12 INVESTIGATOR 1 Baseline No physical damage or very minor physical damage Behavior likely to result in injury but not likely to cause death 0 0 INVESTIGATOR 1 Baseline 1 1 INVESTIGATOR 1 Baseline 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) 4 SDTM Mapping Strategy Baseline specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSORRESU, QSSTRESC, QSSTRESN, and QSSTRESU) should be populated for each questionnaire. If a result variable is not included in the table for a questionnaire, it should not be populated. QSTESTCD= CSS0101 CSS0105 Ideation With Plan/Intent QSORRES Yes No QSTEST= CSS01-Wish to be Dead CSS01- QSSTRESC Y N QSTESTCD= CSS0106 QSTEST= Severe Ideation 1 1 1 2 2 2 3 3 3 4 4 4 5 5 5 QSTESTCD= CSS0107 QSTEST= Severe Ideation, Frequency Less than once a week 1 1 Once a week 2 2 2-5 times in week 3 3 Daily or almost daily 4 4 Many times each day 5 5 QSTESTCD= CSS0108 QSTEST= Severe Ideation, Duration Fleeting few seconds or minutes 1 1 Less than 1 hour/some of the time 2 2 1-4 hours/a lot of time 3 3 4-8 hours/most of day 4 4 More than 8 hours/persistent or continuous 5 5 QSTESTCD= CSS0109 QSTEST= Severe Ideation, Control Easily able to control thoughts 1 1 Can control thoughts with little difficulty 2 2 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) Can control thoughts with some difficulty 3 3 Can control thoughts with a lot of difficulty 4 4 Unable to control thoughts 5 5 Does not attempt to control thoughts 0 0 QSTESTCD= CSS0110 QSTEST= Severe Ideation, Deterrents Deterrents definitely stopped you from attempting suicide 1 1 Deterrents probably stopped you 2 2 Uncertain that deterrents stopped you 3 3 Deterrents most likely did not stop you 4 4 Deterrents definitely did not stop you 5 5 Does not apply 0 0 QSTESTCD= CSS0111 QSTEST= Severe Ideation, Reasons Completely to get attention, revenge or a reaction from others 1 1 Mostly to get attention, revenge or a reaction from others 2 2 Equally to get attention, revenge or a reaction from others and to end/stop the pain 3 3 Mostly to end or stop the pain 4 4 Completely to end or stop pain 5 5 Dose not apply 0 0 QSTESTCD= CSS0112 CSS0120 Suicidal Behavior QSORRES Yes No QSTEST= CSS01-Actual Attempt CSS01- QSSTRESC Y N QSTESTCD= CSS0121B QSTEST= Recent Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage 1 1 Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death 5 5 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 8

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) QSTESTCD= CSS0121C QSTEST= Recent Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 Behavior likely to result in death despite available medical care 2 2 QSTESTCD= CSS0122B QSTEST= Lethal Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage 1 1 Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death 5 5 QSTESTCD= CSS0122C QSTEST= Lethal Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 Behavior likely to result in death despite available medical care 2 2 QSTESTCD= CSS0123B QSTEST= CSS01-First Attempt Damage No physical damage or very minor physical damage 0 0 Minor physical damage 1 1 Moderate physical damage; medical attention needed 2 2 Moderately severe physical damage; medical hospitalization and likely intensive care required 3 3 Severe physical damage; medical hospitalization with intensive care required 4 4 Death 5 5 QSTESTCD= CSS0123C QSTEST= CSS01-First Attempt Potential Behavior not likely to result in injury 0 0 Behavior likely to result in injury but not likely to cause death 1 1 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 9

CDISC SDTM Baseline Questionnaire Supplement (Version 1.0) Behavior likely to result in death despite available medical care 2 2 End of Document 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 10